Anthracycline-induced cardiovascular toxicity: validation of the Heart Failure Association and International Cardio-Oncology Society risk score.

MLA

Rivero-Santana, Borja, et al. “Anthracycline-Induced Cardiovascular Toxicity: Validation of the Heart Failure Association and International Cardio-Oncology Society Risk Score.” European Heart Journal, vol. 46, no. 3, Jan. 2025, pp. 273–84. EBSCOhost, https://doi.org/10.1093/eurheartj/ehae496.

APA

Rivero-Santana, B., Saldaña-García, J., Caro-Codón, J., Zamora, P., Moliner, P., Monzonis, A. M., Zatarain, E., Álvarez-Ortega, C., Gómez-Prieto, P., Pernas, S., Rodriguez, I., Soto, A. B., Cadenas, R., Ozores, P. P., Ramírez, S. P., Salvador, M. M., Valbuena, S., Gasso, L. F., Juárez, V., & Severo, A. (2025). Anthracycline-induced cardiovascular toxicity: validation of the Heart Failure Association and International Cardio-Oncology Society risk score. European Heart Journal, 46(3), 273–284. https://doi.org/10.1093/eurheartj/ehae496

Chicago

Rivero-Santana, Borja, Jesús Saldaña-García, Juan Caro-Codón, Pilar Zamora, Pedro Moliner, Amparo Martínez Monzonis, Eduardo Zatarain, et al. 2025. “Anthracycline-Induced Cardiovascular Toxicity: Validation of the Heart Failure Association and International Cardio-Oncology Society Risk Score.” European Heart Journal 46 (3): 273–84. doi:10.1093/eurheartj/ehae496.